Singapore PM Lee tests positive for Covid positive again in rebound case, says he feels fine

Singapore PM Lee tests positive for Covid positive again in rebound case, says he feels fine


Singapore Prime Minister Lee Hsien Loong has tested positive again for Covid-19 Thursday, a week and a half after his initial diagnosis, in what his doctors say is a case of rebound infection.

Martin Ollman | Getty Images News | Getty Images

SINGAPORE — Singapore Prime Minister Lee Hsien Loong has tested positive again for Covid-19 a week and a half after his initial diagnosis, in what his doctors said is a case of rebound infection.

“I feel fine but I am afraid I have turned COVID-19 positive again,” Lee said Thursday on social media. “My doctors say it is a Covid rebound, which happens in 5-10% of cases. It is still infectious although the risk is not high compared to the initial infection.”

As a result, Lee missed the consecration ceremony of a Hindu temple in Singapore. His reinfection comes as Singapore prepares to host top defense leaders from Asia Pacific at this weekend’s Shangri-La Dialogue, including China defense minister, Gen. Li Shangfu, U.S. Secretary of Defense Lloyd Austin and Australian Prime Minister Anthony Albanese.

Lee, who is 71-years-old, was prescribed the antiviral medication Paxlovid when he first tested positive on May 22 after returning from a six-day official working trip to South Africa and Kenya. He has been serving as prime minister of the Southeast Asian city-state since 2004.

Singapore is coming off an April peak in Covid-19 infections and its government has been lauded for its largely effective handling of the pandemic.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites 
Health

Healthy Returns: FDA launches program to streamline creation of new U.S. drug manufacturing sites 

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A new […]

Read More
FDA may pull authorization of Pfizer’s Covid vaccine for children under 5
Health

FDA may pull authorization of Pfizer’s Covid vaccine for children under 5

A nurse prepares doses of the Pfizer vaccine during a COVID-19 vaccination event at Josephine’s Southern Cooking in Chatham, Illinois, Dec. 30, 2021. Brian Cassella | Tribune News Service | Getty Images The Food and Drug Administration is weighing revoking its authorization of Pfizer‘s Covid-19 vaccine for healthy children under the age of 5, the […]

Read More
Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar
Health

Eli Lilly hikes 2025 outlook, tops quarterly estimates as Mounjaro, Zepbound sales soar

The Eli Lilly logo is shown on one of the company’s offices in San Diego, California, on Sept. 17, 2020. Mike Blake | Reuters Eli Lilly on Thursday hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs. The company raised its fiscal 2025 […]

Read More